4.5 Article

Radiosynthesis and ex vivo evaluation of [18F]-(S)-3-(6-(3-fluoropropoxy)benzo[d]isoxazol-3-yl)-5-(methoxymethyl)oxazolidin-2-one for imaging MAO-B with PET

Journal

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Volume 25, Issue 2, Pages 288-291

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2014.11.048

Keywords

Positron emission tomography; Fluorine-18; SL25.1188; MAO-B

Funding

  1. Ontario Ministry of Research and Innovation

Ask authors/readers for more resources

Carbon-11 labeled SL25.1188 ((S)-5-(methoxymethyl)-3-(6-(4,4,4-trifluorobutoxy) benzo[d] isoxazol-3yl) oxazolidin-2-one) is a reversible radiotracer for monoamine oxidase B that was recently evaluated in healthy volunteers by positron emission tomography (PET). Herein we report the preparation and ex vivo evaluation of a fluorinated SL25.1188 derivative as a candidate 18F-labeled PET radiotracer. (S)-3-(6-(3-fluoropropoxy) benzo[d] isoxazol-3-yl)-5-(methoxy methyl) oxazolidin-2-one (1) was labeled with fluorine-18 in 51% uncorrected radiochemical yield having high radiochemical purity (> 98%) and specific activity (109 26 GBq/lmol). Ex vivo biodistribution studies demonstrated low radioactivity retention, specific binding and metabolic stability within rat brains. High uptake of radioactivity in bone is consistent with metabolic defluorination. In vitro binding assays of longer chain fluoroalkoxy derivatives revealed that the length of the carbon chain is an integral feature in MAO-B inhibitor potency and selectivity within this scaffold. (C) 2014 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Microglia imaging in methamphetamine use disorder: a positron emission tomography study with the 18 kDa translocator protein radioligand [F-18]FEPPA

Gausiha Rathitharan, Jennifer Truong, Junchao Tong, Tina McCluskey, Jeffrey H. Meyer, Romina Mizrahi, Jerry Warsh, Pablo Rusjan, James L. Kennedy, Sylvain Houle, Stephen J. Kish, Isabelle Boileau

Summary: Research on the brains of chronic MA users suggests that while there is activation of microglial cells, there is no significant increase in microgliosis. This indicates that microglia may not be a substantial therapeutic target for MA addiction, despite their involvement in MA-seeking behavior.

ADDICTION BIOLOGY (2021)

Article Psychiatry

Lower amygdala fatty acid amide hydrolase in violent offenders with antisocial personality disorder: an [11C]CURB positron emission tomography study

Nathan J. Kolla, Isabelle Boileau, Karolina Karas, Jeremy J. Watts, Pablo Rusjan, Sylvain Houle, Romina Mizrahi

Summary: Individuals with ASPD have lower FAAH density in the amygdala, while FAAH expression in the cerebellum and striatum is inversely related to impulsivity. Cerebellar FAAH density is also negatively associated with assaultive aggression.

TRANSLATIONAL PSYCHIATRY (2021)

Article Neurosciences

Anxiety in Parkinson's disease: Abnormal resting activity and connectivity

Marion Criaud, Jin-Hee Kim, Mateusz Zurowski, Nancy Lobaugh, Sofia Chavez, Sylvain Houle, Antonio P. Strafella

Summary: The study found that anxiety symptoms in Parkinson's disease patients are associated with over-activation of the amygdala and impaired inter-relationship among regions involved in behavior and motor control.

BRAIN RESEARCH (2021)

Article Cardiac & Cardiovascular Systems

Simultaneous measurements of myocardial glucose metabolism and extracellular volumes with hybrid PET/MRI using concurrent injections of Gd-DTPA and [18F]FDG

H. Smailovic, B. Wilk, G. Wisenberg, J. Sykes, J. Butler, J. Hicks, J. D. Thiessen, F. S. Prato

Summary: The study found that using heparin to suppress myocardial uptake of [F-18]FDG did not alter the determination of myocardial ECV, and the choice of infusion protocol also had no effect on the calculated ECV.

JOURNAL OF NUCLEAR CARDIOLOGY (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

A Noninvasive Method for Quantifying Cerebral Metabolic Rate of Oxygen by Hybrid PET/MRI: Validation in a Porcine Model

Lucas Narciso, Tracy Ssali, Linshan Liu, Heather Biernaski, John Butler, Laura Morrison, Jennifer Hadway, Jeffrey Corsaut, Justin W. Hicks, Michael C. Langham, Felix W. Wehrli, Hidehiro Iida, Keith St Lawrence

Summary: A noninvasive PET/MRI technique for imaging cerebral metabolic rate of oxygen (CMRO2) was proposed and validated in an animal study. The technique uses functional MRI to calibrate PET data, potentially reducing the complexity of PET imaging. The results showed good agreement between regional CMRO2 measurements from the new technique and traditional PET-alone measurements.

JOURNAL OF NUCLEAR MEDICINE (2021)

Article Neurosciences

Fatty acid amide hydrolase binding is inversely correlated with amygdalar functional connectivity: a combined positron emission tomography and magnetic resonance imaging study in healthy individuals

Duncan G. J. Green, Jinhee Kim, Stephen J. Kish, Rachel F. Tyndale, Matthew N. Hill, Antonio P. Strafella, Junchao Tong, Tina McCluskey, Duncan J. Westwood, Sylvain Houle, Nancy J. Lobaugh, Isabelle Boileau

Summary: This study revealed a negative correlation between levels of the endocannabinoid enzyme fatty acid amide hydrolase (FAAH) in the amygdala and functional connectivity in frontoamygdalar circuits involved in stress and affect control. The findings provide preliminary evidence supporting the role of FAAH in regulating brain circuits underlying fear and emotion processing in humans.

JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2021)

Correction Neurosciences

Elevated fatty acid amide hydrolase in the prefrontal cortex of borderline personality disorder: a [11C] CURB positron emission tomography study (vol 45, pg 1834, 2020)

J. Kolla Nathan, R. Mizrahi, K. Karas, C. Wang, R. M. Bagby, S. McMain, A. I. Simpson, P. M. Rusjan, R. Tyndale, S. Houle, I. Boileau

Summary: The correction to this paper has been published.

NEUROPSYCHOPHARMACOLOGY (2021)

Article Multidisciplinary Sciences

The influence of conditioned stimuli on [11C]-(+)-PHNO PET binding in tobacco smokers after a one week abstinence

Patricia Di Ciano, Harriet de Wit, Esmaeil Mansouri, Sylvain Houle, Isabelle Boileau, Bernard Le Foll

Summary: PET imaging with [C-11]-(+)-PHNO was used to measure changes in dopamine levels in regions of interest in smokers who had maintained abstinence for 7-10 days. Results showed that smoking cues did not increase craving, and there were no significant changes in dopamine binding potential in most regions except for a decrease in the substantia nigra. Further research with a larger sample size is needed to validate these preliminary findings.

SCIENTIFIC REPORTS (2021)

Article Psychiatry

A double-blind placebo-controlled trial of minocycline on translocator protein distribution volume in treatment-resistant major depressive disorder

Sophia Attwells, Elaine Setiawan, Pablo M. Rusjan, Cynthia Xu, Stephen J. Kish, Neil Vasdev, Sylvain Houle, Apitharani Santhirakumar, Jeffrey H. Meyer

Summary: Oral minocycline did not significantly reduce TSPO V-T in TRD patients, suggesting that this dosage may be insufficient for reducing gliosis in this condition. Alternative therapeutic approaches or intravenous formulations of minocycline should be considered for targeting gliosis in TRD. Additionally, it should not be assumed that oral minocycline will reduce TSPO V-T or gliosis in humans without empirical evidence.

TRANSLATIONAL PSYCHIATRY (2021)

Article Clinical Neurology

Imaging of astrocytes in posttraumatic stress disorder: A PET study with the monoamine oxidase B radioligand [11C]SL25.1188

Talwinder Gill, Sarah E. Watling, J. Don Richardson, Tina McCluskey, Junchao Tong, Jeffrey H. Meyer, Jerry Warsh, Rakesh Jetly, Michael G. Hutchison, Shawn G. Rhind, Sylvain Houle, Neil Vasdev, Stephen J. Kish, Isabelle Boileau

Summary: Posttraumatic stress disorder (PTSD) may be associated with astrocyte pathology and a decrease in MAO-B levels. Preliminary results suggest a potential reduction in [C-11]SL25.1188 availability in PTSD patients, especially those with comorbid major depressive disorder (MDD). These findings are partly consistent with preclinical studies and recent PET observations, but further replication in a larger PTSD cohort is needed.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2022)

Article Neuroimaging

Concordance of regional hypoperfusion by pCASL MRI and 15O-water PET in frontotemporal dementia: Is pCASL an efficacious alternative?

Tracy Ssali, Lucas Narciso, Justin Hicks, Linshan Liu, Sarah Jesso, Lauryn Richardson, Matthias Gunther, Simon Konstandin, Klaus Eickel, Frank Prato, Udunna C. Anazodo, Elizabeth Finger, Keith St Lawrence

Summary: This study evaluated the similarity between ASL and PET in diagnosing FTD, and the results showed that ASL has the potential to be a cost-effective alternative.

NEUROIMAGE-CLINICAL (2022)

Article Chemistry, Inorganic & Nuclear

Low cost and open source purification apparatus for GMP [13N] Ammonia production

Farah Kamar, Michael S. Kovacs, Justin W. Hicks

Summary: This study developed and validated an Arduino-based device for purifying [N-13]NH3, aiming to address the increased production costs caused by stricter regulatory oversight. The results showed that the automated method could produce equivalent quality radiopharmaceutical as the manual method, with better reproducibility and robustness.

APPLIED RADIATION AND ISOTOPES (2022)

Article Clinical Neurology

Investigating the use of plasma pTau181 in retired contact sports athletes

Anna Vasilevskaya, Foad Taghdiri, Namita Multani, Miracle Ozzoude, Apameh Tarazi, Mozhgan Khodadadi, Richard Wennberg, Pablo Rusjan, Sylvain Houle, Robin Green, Brenda Colella, Kaj Blennow, Henrik Zetterberg, Thomas Karikari, David Mikulis, Lili-Naz Hazrati, Gabor G. Kovacs, Karen Deborah Davis, Charles Tator, Maria Carmela Tartaglia

Summary: This study investigated the use of plasma pTau181 as a non-invasive measure to assess the risk of neurodegenerative diseases in retired athletes. The results showed that retired athletes had higher levels of plasma pTau181 and its levels were associated with abnormalities in certain brain regions. However, baseline pTau181 levels were not predictive of longitudinal changes in brain volumes or white-matter integrity in the athletes.

JOURNAL OF NEUROLOGY (2022)

Article Neurosciences

In vivo brain endocannabinoid metabolism is related to hippocampus glutamate and structure - a multimodal imaging study with PET, 1H-MRS, and MRI

Jeremy J. Watts, Elisa Guma, Sofia Chavez, Rachel F. Tyndale, Ruth A. Ross, Sylvain Houle, Alan A. Wilson, Mallar Chakravarty, Pablo M. Rusjan, Romina Mizrahi

Summary: Dysregulation of hippocampus neurotransmission and volume has been associated with psychiatric disorders, and anandamide and FAAH are related to normal hippocampus function.

NEUROPSYCHOPHARMACOLOGY (2022)

Article Psychiatry

Imaging oxidative stress in brains of chronic methamphetamine users: A combined 1H-magnetic resonance spectroscopy and peripheral blood biomarker study

Sarah E. Watling, Samantha Jagasar, Tina McCluskey, Jerry Warsh, Shawn G. Rhind, Peter Truong, Sofia Chavez, Sylvain Houle, Junchao Tong, Stephen J. Kish, Isabelle Boileau

Summary: Preliminary data suggests that chronic methamphetamine (MA) use may cause oxidative stress and inflammation in the brain. This study aimed to investigate the levels of the antioxidant glutathione (GSH) in the brains of chronic MA users and explore the relationship between peripheral immunoinflammatory biomarkers and brain GSH concentrations. The results showed that GSH levels did not differ between MA users and healthy controls, but several immunoinflammatory biomarkers were significantly elevated in MA users and correlated with brain GSH levels.

FRONTIERS IN PSYCHIATRY (2023)

Article Chemistry, Medicinal

Design and synthesis of a library of C2-substituted sulfamidoadenosines to probe bacterial permeability

Shibin Zhao, Julian Maceren, Mia Chung, Samantha Stone, Raphael Geiben, Melissa L. Boby, Bradley S. Sherborne, Derek S. Tan

Summary: Antibiotic resistance is a major threat to public health, with Gram-negative bacteria presenting unique challenges due to their low permeability and efflux pumps. Limited understanding of the chemical rules for overcoming these barriers hinders antibacterial drug discovery. Efforts to address this issue, such as screening compound libraries and using cheminformatic analysis, have led to the design of sulfamidoadenosines with diverse substituents, showing potential utility in accumulation in Escherichia coli.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Design of MERS-CoV entry inhibitory short peptides based on helix-stabilizing strategies

Jichun Li, Qing Li, Shuai Xia, Jiahuang Tu, Longbo Zheng, Qian Wang, Shibo Jiang, Chao Wang

Summary: This study successfully developed a short peptide mimetic as a MERS-CoV fusion inhibitor by reproducing the key recognition features of the HR2 helix. The resulting 23-mer lipopeptide showed comparable inhibitory effect to the 36-mer HR2 peptide HR2P-M2. This has important implications for developing short peptide-based antiviral agents to treat MERS-CoV infection.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Development of novel β2-adrenergic receptor agonists for the stimulation of glucose uptake - The importance of chirality and ring size of cyclic amines

Krista Jaunsleine, Linda Supe, Jana Spura, Sten van Beek, Anna Sandstrom, Jessica Olsen, Carina Halleskog, Tore Bengtsson, Ilga Mutule, Benjamin Pelcman

Summary: Beta(2)-adrenergic receptor agonists can stimulate glucose uptake by skeletal muscle cells and are therefore potential treatments for type 2 diabetes. The chirality of compounds has a significant impact on the activity of these agonists. This study found that certain synthesized compounds showed higher glucose uptake activity. These findings provide important information for the design of novel beta(2)AR agonists for T2D treatment.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Conformationally constrained potent inhibitors for enhancer of zeste homolog 2 (EZH2)

Xin Xu, Jia Chen, Guan Wang, Xiaojuan Zhang, Qiang Li, Xiaobo Zhou, Fengying Guo, Min Li

Summary: The study focuses on EZH2, a promising therapeutic target for various types of cancers. Researchers designed and synthesized a series of novel derivatives aiming to enhance the EZH2 inhibition activity. Among them, compound 28 displayed potent EZH2 inhibition activity and showed high anti-proliferative effects in lymphoma cell lines and xenograft mouse models. The study suggests that compound 28 has potential as a therapeutic candidate for EZH2-associated cancers.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

The potential of Rhein's aromatic amines for Parkinson's disease prevention and treatment: α-Synuclein aggregation inhibition and disaggregation of preformed fibers

Wei Zhang, Wei Liu, Ya-Dong Zhao, Li-Zi Xing, Ji Xu, Rui-Jun Li, Yun-Xiao Zhang

Summary: This study developed a series of aromatic amide derivatives based on Rhein and investigated their inhibitory activity against alpha-Syn aggregation. Two of these compounds showed promising potential in treating Parkinson's disease by stabilizing alpha-Syn's conformation and disassembling alpha-Syn oligomers and fibrils.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Design, synthesis and biological evaluation of novel cationic liposomes loaded with melphalan for the treatment of cancer

Mani Sharma, S. S. S. S. Sudha Ambadipudi, Neeraj Kumar Chouhan, V. Lakshma Nayak, Srihari Pabbaraja, Sai Balaji Andugulapati, Ramakrishna Sistla

Summary: Therapeutically active lipids in drug delivery systems can enhance the safety and efficacy of treatment. The liposome formulation created using synthesized biologically active lipids showed additive anti-cancer effects and reduced tumorigenic potential.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)